These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response. Liu W; Huber SA Virol J; 2011 Jan; 8():32. PubMed ID: 21255407 [TBL] [Abstract][Full Text] [Related]
27. Bcl-xL regulates CD1d-mediated antigen presentation to NKT cells by altering CD1d trafficking through the endocytic pathway. Subrahmanyam PB; Carey GB; Webb TJ J Immunol; 2014 Sep; 193(5):2096-105. PubMed ID: 25070854 [TBL] [Abstract][Full Text] [Related]
28. The interaction between invariant Natural Killer T cells and the mucosal microbiota. Hapil FZ; Wingender G Immunology; 2018 Oct; 155(2):164-175. PubMed ID: 29893412 [TBL] [Abstract][Full Text] [Related]
29. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease. Maricic I; Girardi E; Zajonc DM; Kumar V J Immunol; 2014 Nov; 193(9):4580-9. PubMed ID: 25261475 [TBL] [Abstract][Full Text] [Related]
30. Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1. Ying G; Wang J; Mallevaey T; Van Calenbergh S; Zajonc DM J Biol Chem; 2019 Aug; 294(35):12947-12956. PubMed ID: 31296659 [TBL] [Abstract][Full Text] [Related]
31. NKT Cells Contribute to the Control of Microbial Infections. Vogt S; Mattner J Front Cell Infect Microbiol; 2021; 11():718350. PubMed ID: 34595131 [TBL] [Abstract][Full Text] [Related]
32. Harnessing CD1d-restricted T cells toward antitumor immunity in humans. Neparidze N; Dhodapkar MV Ann N Y Acad Sci; 2009 Sep; 1174():61-7. PubMed ID: 19769737 [TBL] [Abstract][Full Text] [Related]
33. Role of NKT cells in the digestive system. IV. The role of canonical natural killer T cells in mucosal immunity and inflammation. Wingender G; Kronenberg M Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G1-8. PubMed ID: 17947447 [TBL] [Abstract][Full Text] [Related]
34. Type II NKT Cells: An Elusive Population With Immunoregulatory Properties. Singh AK; Tripathi P; Cardell SL Front Immunol; 2018; 9():1969. PubMed ID: 30210505 [TBL] [Abstract][Full Text] [Related]
35. Targeting Natural Killer T Cells in Solid Malignancies. Ingram Z; Madan S; Merchant J; Carter Z; Gordon Z; Carey G; Webb TJ Cells; 2021 May; 10(6):. PubMed ID: 34072042 [TBL] [Abstract][Full Text] [Related]
36. Detection of Autoreactive Type II NKT Cells: A Pilot Study of Comparison Between Healthy Individuals and Patients with Vasculitis. Nishioka Y; Sonoda T; Shida H; Kusunoki Y; Hattanda F; Tanimura S; Uozumi R; Yamada M; Nishibata Y; Masuda S; Nakazawa D; Tomaru U; Atsumi T; Ishizu A Cytometry A; 2018 Nov; 93(11):1157-1164. PubMed ID: 30253046 [TBL] [Abstract][Full Text] [Related]
37. Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d. Almeida CF; Smith DGM; Cheng TY; Harpur CM; Batleska E; Nguyen-Robertson CV; Nguyen T; Thelemann T; Reddiex SJJ; Li S; Eckle SBG; Van Rhijn I; Rossjohn J; Uldrich AP; Moody DB; Williams SJ; Pellicci DG; Godfrey DI Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34417291 [TBL] [Abstract][Full Text] [Related]
38. Natural killer T cells in lipoprotein metabolism and atherosclerosis. Getz GS; Vanderlaan PA; Reardon CA Thromb Haemost; 2011 Nov; 106(5):814-9. PubMed ID: 21946866 [TBL] [Abstract][Full Text] [Related]
39. Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease. Weng X; He Y; Visvabharathy L; Liao CM; Tan X; Balakumar A; Wang CR J Hepatol; 2017 Oct; 67(4):791-800. PubMed ID: 28596110 [TBL] [Abstract][Full Text] [Related]
40. Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells. Webb TJ; Bieler JG; Schneck JP; Oelke M J Immunol Methods; 2009 Jul; 346(1-2):38-44. PubMed ID: 19446558 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]